139 related articles for article (PubMed ID: 12480690)
1. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.
Chauhan D; Auclair D; Robinson EK; Hideshima T; Li G; Podar K; Gupta D; Richardson P; Schlossman RL; Krett N; Chen LB; Munshi NC; Anderson KC
Oncogene; 2002 Feb; 21(9):1346-58. PubMed ID: 11857078
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.
Chauhan D; Li G; Auclair D; Hideshima T; Podar K; Mitsiades N; Mitsiades C; Chen LB; Munshi N; Saxena S; Anderson KC
Apoptosis; 2004 Mar; 9(2):149-55. PubMed ID: 15004512
[TBL] [Abstract][Full Text] [Related]
4. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
[TBL] [Abstract][Full Text] [Related]
5. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
6. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
7. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
Hou J; Xiong H; Gao W; Jiang H
Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the effect of 2-methoxyestradiol and arsenic trioxide on the apoptosis-associated gene expression profile of myeloma cells].
Xiong H; Hou J; Gao WR; Chen QB
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):200-4. PubMed ID: 15949259
[TBL] [Abstract][Full Text] [Related]
9. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells.
Thompson HG; Harris JW; Wold BJ; Lin F; Brody JP
Oncogene; 2003 Apr; 22(15):2322-33. PubMed ID: 12700667
[TBL] [Abstract][Full Text] [Related]
10. 2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells.
Bhati R; Gökmen-Polar Y; Sledge GW; Fan C; Nakshatri H; Ketelsen D; Borchers CH; Dial MJ; Patterson C; Klauber-DeMore N
Cancer Res; 2007 Jan; 67(2):702-8. PubMed ID: 17234781
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
Gao WR; Hou J; Xiong H
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
[TBL] [Abstract][Full Text] [Related]
12. [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
Gao WR; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):293-7. PubMed ID: 15854295
[TBL] [Abstract][Full Text] [Related]
13. Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma.
Iyer R; Ding L; Batchu RB; Naugler S; Shammas MA; Munshi NC
Leuk Res; 2003 Jan; 27(1):73-8. PubMed ID: 12479855
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
Zhou X; Zhou F; Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
[TBL] [Abstract][Full Text] [Related]
15. Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
Liaw TY; Salam NK; McKay MJ; Cunningham AM; Hibbs DE; Kavallaris M
Mol Cancer Ther; 2008 Oct; 7(10):3150-9. PubMed ID: 18852118
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons.
Holtz WA; O'Malley KL
J Biol Chem; 2003 May; 278(21):19367-77. PubMed ID: 12598533
[TBL] [Abstract][Full Text] [Related]
17. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
[TBL] [Abstract][Full Text] [Related]
18. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV
Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611
[TBL] [Abstract][Full Text] [Related]
19. 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor.
Koganti S; Snyder R; Gumaste U; Karamyan VT; Thekkumkara T
Eur J Pharmacol; 2014 Jan; 723():131-40. PubMed ID: 24262995
[TBL] [Abstract][Full Text] [Related]
20. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
Mooberry SL
Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
